Literature DB >> 20189995

Improved insulin sensitivity in high fat- and high cholesterol-fed Ldlr-/- mice with macrophage-specific transgenic expression of cholesteryl ester hydrolase: role of macrophage inflammation and infiltration into adipose tissue.

Jinghua Bie1, Bin Zhao, Jingmei Song, Shobha Ghosh.   

Abstract

Cellular cholesterol balance induces changes in the inflammatory status of macrophages, and low grade chronic inflammation is increasingly being recognized as one of the key steps in the development of atherosclerosis as well as insulin resistance. Cholesteryl ester hydrolase (CEH) catalyzes the hydrolysis of intracellular stored cholesteryl esters (CEs) and thereby enhances free cholesterol efflux and reduces cellular CE content. We have earlier reported reduced atherosclerosis and lesion necrosis in macrophage-specific CEH transgenic mice on a Ldlr(-/-) background. In the present study, we tested the hypothesis that reduced intracellular accumulation of CE in macrophages from CEH transgenic mice will attenuate expression of proinflammatory mediators, thereby reducing infiltration into adipose tissue, alleviating inflammation, and resulting in improved insulin sensitivity. Western diet fed Ldlr(-/-)CEH transgenic mice showed improved insulin sensitivity as assessed by glucose and insulin tolerance tests. Macrophages from CEH transgenic mice expressed significantly lower levels of proinflammatory cytokines (interleukin-1beta and interleukin-6) and chemokine (MCP-1; monocyte chemoattractant protein). Attenuation of NF-kappaB- and AP-1-driven gene expression was determined to be the underlying mechanism. Infiltration of macrophages into the adipose tissue that increases inflammation and impairs insulin signaling was also significantly reduced in Ldlr(-/-)CEH transgenic mice. In the OP-9 adipocyte peritoneal macrophage co-culture system, macrophages from CEH transgenic mice had a significantly reduced effect on insulin signaling as measured by Akt phosphorylation compared with nontransgenic macrophages. Taken together, these studies demonstrate that macrophage-specific overexpression of CEH decreases expression of proinflammatory mediators and attenuates macrophage infiltration into the adipose tissue, resulting in decreased circulating cytokines and improved insulin sensitivity.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20189995      PMCID: PMC2859525          DOI: 10.1074/jbc.M109.069781

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  31 in total

Review 1.  The inflamed plaque: cytokine production and cellular cholesterol balance in the vessel wall.

Authors:  S Fazio; M F Linton
Journal:  Am J Cardiol       Date:  2001-07-19       Impact factor: 2.778

2.  Metabolic and endocrine actions of interleukin-1. Effects on insulin-resistant animals.

Authors:  H O Besedovsky; A Del Rey
Journal:  Ann N Y Acad Sci       Date:  1990       Impact factor: 5.691

Review 3.  The inflammatory syndrome: the role of adipose tissue cytokines in metabolic disorders linked to obesity.

Authors:  Brent E Wisse
Journal:  J Am Soc Nephrol       Date:  2004-11       Impact factor: 10.121

4.  Tumor necrosis factor-alpha exerts interleukin-6-dependent and -independent effects on cultured skeletal muscle cells.

Authors:  Belen Alvarez; LeBris S Quinn; Sijlvia Busquets; Maria T Quiles; Francisco J Lopez-Soriano; Josep M Argiles
Journal:  Biochim Biophys Acta       Date:  2002-01-30

5.  Chronic interleukin-6 (IL-6) treatment increased IL-6 secretion and induced insulin resistance in adipocyte: prevention by rosiglitazone.

Authors:  Claire Lagathu; Jean-Philippe Bastard; Martine Auclair; Mustapha Maachi; Jacqueline Capeau; Martine Caron
Journal:  Biochem Biophys Res Commun       Date:  2003-11-14       Impact factor: 3.575

6.  Mobilization of cytoplasmic CE droplets by overexpression of human macrophage cholesteryl ester hydrolase.

Authors:  Shobha Ghosh; Richard W St Clair; Lawrence L Rudel
Journal:  J Lipid Res       Date:  2003-07-01       Impact factor: 5.922

Review 7.  Interleukin-1 beta targeted therapy for type 2 diabetes.

Authors:  Kathrin Maedler; Gitanjali Dharmadhikari; Desiree M Schumann; Joachim Størling
Journal:  Expert Opin Biol Ther       Date:  2009-09       Impact factor: 4.388

Review 8.  Adipokines: inflammation and the pleiotropic role of white adipose tissue.

Authors:  Paul Trayhurn; I Stuart Wood
Journal:  Br J Nutr       Date:  2004-09       Impact factor: 3.718

Review 9.  The cell cholesterol exporter ABCA1 as a protector from cardiovascular disease and diabetes.

Authors:  Chongren Tang; John F Oram
Journal:  Biochim Biophys Acta       Date:  2009-04-01

10.  Conjugated linoleic acid induces human adipocyte delipidation: autocrine/paracrine regulation of MEK/ERK signaling by adipocytokines.

Authors:  J Mark Brown; Maria Sandberg Boysen; Soonkyu Chung; Olowatoyin Fabiyi; Ron F Morrison; Susanne Mandrup; Michael K McIntosh
Journal:  J Biol Chem       Date:  2004-04-02       Impact factor: 5.157

View more
  26 in total

1.  Impaired compensatory beta-cell function and growth in response to high-fat diet in LDL receptor knockout mice.

Authors:  Ricardo B d Oliveira; Carolina P d F Carvalho; Carla C Polo; Gabriel d G Dorighello; Antônio C Boschero; Helena C F d Oliveira; Carla B Collares-Buzato
Journal:  Int J Exp Pathol       Date:  2014-05-23       Impact factor: 1.925

Review 2.  Lipid biology of the podocyte--new perspectives offer new opportunities.

Authors:  Alessia Fornoni; Sandra Merscher; Jeffrey B Kopp
Journal:  Nat Rev Nephrol       Date:  2014-05-27       Impact factor: 28.314

Review 3.  Curcumin-mediated regulation of intestinal barrier function: The mechanism underlying its beneficial effects.

Authors:  Siddhartha S Ghosh; Hongliang He; Jing Wang; Todd W Gehr; Shobha Ghosh
Journal:  Tissue Barriers       Date:  2018-02-08

4.  Regulation of interleukin-1 beta secretion from macrophages via modulation of potassium ion (K+ ) channel activity.

Authors:  Jing Wang; Paul J Yannie; Siddhartha S Ghosh; Shobha Ghosh
Journal:  FEBS Lett       Date:  2019-05-08       Impact factor: 4.124

5.  Macrophage-specific transgenic expression of cholesteryl ester hydrolase attenuates hepatic lipid accumulation and also improves glucose tolerance in ob/ob mice.

Authors:  Jinghua Bie; Bin Zhao; Kathryn E Marqueen; Jing Wang; Barbara Szomju; Shobha Ghosh
Journal:  Am J Physiol Endocrinol Metab       Date:  2012-03-06       Impact factor: 4.310

6.  Myeloid-specific Acat1 ablation attenuates inflammatory responses in macrophages, improves insulin sensitivity, and suppresses diet-induced obesity.

Authors:  Li-Hao Huang; Elaina M Melton; Haibo Li; Paul Sohn; DaeYoung Jung; Ching-Yi Tsai; Tian Ma; Hiroyuki Sano; HyeKyung Ha; Randall H Friedline; Jason K Kim; Edward Usherwood; Catherine C Y Chang; Ta-Yuan Chang
Journal:  Am J Physiol Endocrinol Metab       Date:  2018-03-13       Impact factor: 4.310

Review 7.  Systemic and renal lipids in kidney disease development and progression.

Authors:  Patricia Wahl; Gloria Michelle Ducasa; Alessia Fornoni
Journal:  Am J Physiol Renal Physiol       Date:  2015-12-23

Review 8.  Animal models of nonalcoholic fatty liver disease.

Authors:  Lionel Hebbard; Jacob George
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2010-11-30       Impact factor: 46.802

9.  Atherosclerotic lesion progression is attenuated by reconstitution with bone marrow from macrophage-specific cholesteryl ester hydrolase transgenic mice.

Authors:  Jinghua Bie; Bin Zhao; Shobha Ghosh
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2011-07-27       Impact factor: 3.619

10.  Alterations of a Cellular Cholesterol Metabolism Network Are a Molecular Feature of Obesity-Related Type 2 Diabetes and Cardiovascular Disease.

Authors:  Jingzhong Ding; Lindsay M Reynolds; Tanja Zeller; Christian Müller; Kurt Lohman; Barbara J Nicklas; Stephen B Kritchevsky; Zhiqing Huang; Alberto de la Fuente; Nicola Soranzo; Robert E Settlage; Chia-Chi Chuang; Timothy Howard; Ning Xu; Mark O Goodarzi; Y-D Ida Chen; Jerome I Rotter; David S Siscovick; John S Parks; Susan Murphy; David R Jacobs; Wendy Post; Russell P Tracy; Philipp S Wild; Stefan Blankenberg; Ina Hoeschele; David Herrington; Charles E McCall; Yongmei Liu
Journal:  Diabetes       Date:  2015-07-07       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.